Abstract
Cytomegalovirus (CMV) infection and CMV-associated disease were monitored using the CMV antigenemia assay in 72 patients who received allogeneic bone marrow transplantation (BMT), and their incidences were compared between related and unrelated donor transplant patients. The incidence of CMV infection after BMT was significantly higher in patients who received transplants from HLA-matched unrelated donors than from HLA-matched sibling donors (87% vs 53%, P < 0.05). cmv-associated disease developed in 73% of unrelated and in 14% of sibling donor transplant patients (P < 0.01). the peak levels of cmv antigenemia were significantly higher in unrelated donors than in sibling donor transplant patients (16 vs 1 CMV antigen-positive cells per 50 000 WBCs, P < 0.01). the median number of cmv antigen-positive cells on first detection was also significantly higher in unrelated donor transplant patients (15 vs 1, P < 0.01). the detection of cmv antigen-positive cells preceded the development of cmv-associated disease in 18% of unrelated donor transplant patients, suggesting a lower predictive value of cmv antigenemia for subsequent cmv- associated disease in unrelated donor bmt. careful monitoring and further studies are needed for the early diagnosis and prevention of cmv-associated disease in unrelated donor bmt.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takenaka, K., Gondo, H., Tanimoto, K. et al. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. Bone Marrow Transplant 19, 241–248 (1997). https://doi.org/10.1038/sj.bmt.1700637
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700637
Keywords
This article is cited by
-
Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation
Eye (2023)
-
Efficacy of letermovir in HLA-haploidentical hematopoietic transplantation with posttransplant cyclophosphamide
International Journal of Hematology (2023)
-
Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
International Journal of Hematology (2022)
-
Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study
Bone Marrow Transplantation (2021)
-
Cytomegalovirus DNAemia Detected with Real-Time Polymerase Chain Reaction in Hematopoietic Stem Cell Transplant Patients
Advances in Therapy (2013)